等待开盘 09-11 09:30:00 美东时间
-1.210
-4.56%
Pharming Group N.V. has been promoted to the Euronext AMX (MidCap) index, effective September 22, 2025, reflecting its strong growth momentum. The company, which focuses on rare diseases, aims to enhance visibility and attract investors, supporting its goal of becoming a leading global rare disease company.
09-10 05:00
Phreesia, Inc. (NYSE:PHR) posted mixed results for the second quarter on Thursd...
09-06 03:07
Phreesia gains analyst support with price target hikes, though integration risks and modest guidance raise tempered investor enthusiasm.
09-05 23:23
Needham analyst Ryan MacDonald maintains Phreesia (NYSE:PHR) with a Buy and raises the price target from $29 to $35.
09-05 18:52
Phreesia ( ($PHR) ) has released its Q2 earnings. Here is a breakdown of the in...
09-05 11:54
Gainers iSpecimen (NASDAQ:ISPC) shares rose 52.4% to $1.0 during Thursday's af...
09-05 05:13
Phreesia ( ($PHR) ) has shared an update. On August 29, 2025, Phreesia, Inc. an...
09-05 04:36
Phreesia shares are trading lower. The company reported Q2 financial results.
09-05 04:31
Phreesia (NYSE:PHR) said on Thursday that it has entered into a definitive agreement to acquire AccessOne Parent Holdings, for aggregate consideration of $160M in cash. AccessOne is a market leader i...
09-05 04:16
Phreesia, Inc. (NYSE:PHR) ("Phreesia"), a trusted leader in patient activation, today announced it has entered into a definitive agreement to acquire AccessOne Parent Holdings, Inc. (together with its subsidiaries,
09-05 04:04